Back to search
FDAFDA · Food and drugs·Recall number D-1359-2016

Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32

Published July 20, 2016 · Recall initiated: June 23, 2016

Summary

FDA records drug Class II recall D-1359-2016, published July 20, 2016 and initiated June 23, 2016. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 373,850 tubes; Lot: Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization: Product contains particulate identified to be crystallized active ingredient.

What to do

Voluntary: Firm initiated · Letter

Get an email if DIAZEPAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DIAZEPAM
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32 recalled?

Yes. FDA published recall D-1359-2016 on July 20, 2016. Reported hazard: Crystallization: Product contains particulate identified to be crystallized active ingredient.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DIAZEPAM.